Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Cardiology|October 15, 1994
Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stentingA D Kugelmass, D J Cohen, M Moscucci, et al.Journal of the American College of Cardiology|July 21, 1998
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and RestenosisC M Gibson, M Goel, D J Cohen, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 4, 2001
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofibanD I Simon, C B Liu, P Ganz, et al.Journal of the American College of Cardiology|May 1, 1994
Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcomeR N Piana, M Moscucci, D J Cohen, et al.American Heart Journal|November 5, 1997
Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trialC M Gibson, S J Marble, M J Rizzo, et al.Circulation|June 1, 1994
Incidence and treatment of 'no-reflow' after percutaneous coronary interventionR N Piana, G Y Paik, M Moscucci, et al.The New England Journal of Medicine|November 5, 1992
Predictors of long-term outcome after percutaneous balloon mitral valvuloplastyD J Cohen, R E Kuntz, S P Gordon, et al.Journal of the American College of Cardiology|March 1, 1995
Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trialC M Gibson, C P Cannon, R N Piana, et al.The American Journal of Cardiology|July 1, 1994
Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?P C Gordon, S P Friedrich, R N Piana, et al.American Heart Journal|June 30, 2000
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trialsR P Giugliano, C H McCabe, R F Sequeira, et al.Pageof 2